Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Cogle

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Healthcare (Basel, Switzerland)|November 27, 2024
Participation in Tobacco Cessation Programs Among Medicaid Managed Care Enrollees in FloridaRahma S Mkuu, Casey C Glymph, Peyton A Lurk, et al.
The Oncologist|March 12, 2017
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents FailChristopher R Cogle, Sandra E Kurtin, Tanya G K Bentley, et al.
Frontiers in Oncology|January 31, 2022
<i>Post-hoc</i> Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMAJustin Watts, Tara L Lin, Alice Mims, et al.
Stem Cells (Dayton, Ohio)|May 5, 2007
Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicryChristopher R Cogle, Neil D Theise, Dongtao Fu, et al.
Cancers|November 13, 2021
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436Fatih M Uckun, Justin Watts, Alice S Mims, et al.
Future Oncology (London, England)|December 28, 2020
Novel CD33 antibodies unravel localization, biology and therapeutic implications of CD33 isoformsMohammed O Gbadamosi, Vivek M Shastri, Tiffany Hylkema, et al.
Cancers|August 27, 2021
A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeFatih M Uckun, Tara L Lin, Alice S Mims, et al.
Health Affairs (Project Hope)|January 6, 2026
Impact Of Housing Support Services For Medicaid Enrollees With Serious Mental Illness, Substance Use DisorderTyler Bruefach, Rahma S Mkuu, Jaclyn M Hall, et al.
Experimental Hematology|February 23, 2016
Chemosensitizing AML cells by targeting bone marrow endothelial cellsRaphael C Bosse, Briana Wasserstrom, Amy Meacham, et al.
Blood|March 26, 2005
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34Robert W Storms, Patrick D Green, Kristine M Safford, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Healthcare (Basel, Switzerland)|November 27, 2024
Participation in Tobacco Cessation Programs Among Medicaid Managed Care Enrollees in FloridaRahma S Mkuu, Casey C Glymph, Peyton A Lurk, et al.
The Oncologist|March 12, 2017
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents FailChristopher R Cogle, Sandra E Kurtin, Tanya G K Bentley, et al.
Frontiers in Oncology|January 31, 2022
<i>Post-hoc</i> Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMAJustin Watts, Tara L Lin, Alice Mims, et al.
Stem Cells (Dayton, Ohio)|May 5, 2007
Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicryChristopher R Cogle, Neil D Theise, Dongtao Fu, et al.
Cancers|November 13, 2021
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436Fatih M Uckun, Justin Watts, Alice S Mims, et al.
Future Oncology (London, England)|December 28, 2020
Novel CD33 antibodies unravel localization, biology and therapeutic implications of CD33 isoformsMohammed O Gbadamosi, Vivek M Shastri, Tiffany Hylkema, et al.
Cancers|August 27, 2021
A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeFatih M Uckun, Tara L Lin, Alice S Mims, et al.
Health Affairs (Project Hope)|January 6, 2026
Impact Of Housing Support Services For Medicaid Enrollees With Serious Mental Illness, Substance Use DisorderTyler Bruefach, Rahma S Mkuu, Jaclyn M Hall, et al.
Experimental Hematology|February 23, 2016
Chemosensitizing AML cells by targeting bone marrow endothelial cellsRaphael C Bosse, Briana Wasserstrom, Amy Meacham, et al.
Blood|March 26, 2005
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34Robert W Storms, Patrick D Green, Kristine M Safford, et al.
Pageof 14